Using Identification And Antimicrobial Susceptibility Testing (ID/AST) To Reinvigorate Antimicrobial Stewardship
SUMMARY
bioMérieux experts Chris Groke, PharmD and Stephen Vella, PhD explain the essential role of microbial identification and susceptibility testing within the reprioritizing of antimicrobial stewardship efforts post-COVID. In managing COVID-19, limited resources and treatment options prompted many clinicians to pursue an "anything and everything" approach that, studies reveal, likely led to antibiotic overprescribing. This article draws from leading research to demonstrate how integration of rapid ID/AST solutions can help guide more targeted patient therapy leading to better outcomes - leaving less opportunity for antimicrobial resistance (AMR) to arise.
FEATURED EXPERTS
Chris Groke, PharmD, BCPS, BCIDP, Senior Medical Science Liaison, bioMérieux
Stephen Vella, PhD, Medical Science Liaison, bioMérieux
GET STARTED
Read the Learning Lounge exclusive article
Take Me There Now
- Filename
- LL-Editorial_Using-ID-AST-to-Reinvigorate-AMS---CGroke-and-SVella_December-2023_Final.pdf
- Size
- 739 KB
- Format
- application/pdf
Read time: 6 minutes
PUBLISHED BY
Learning Lounge Exclusive
December 12, 2023
